evacetrapib (uncountable)
- A drug that inhibits cholesterylester transfer protein (CETP).
2015 October 12, Andrew Pollack, “Eli Lilly Abandons Heart Disease Drug in Final Stage of Trials”, in New York Times[1]:By contrast, the CETP inhibitors like evacetrapib are taken orally.
